The DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index; none of the 37 sources its claims cite is checked for support yet.
Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood.
Open accessAbstract
Prospective longitudinal study of methylphenidate-treated boys with ADHD followed into adulthood.
Overview
CoChat Summary
TL;DR
In a prospective follow-up of methylphenidate-treated boys with ADHD, later age at treatment initiation was associated with higher risk of non-alcohol substance use disorder, but this association was explained by later antisocial personality disorder. Early methylphenidate treatment did not increase risk for substance use disorder and may have beneficial long-term effects.
Key findings
- Later age at first methylphenidate treatment significantly predicted Non-Alcohol SUD (Wald χ²=4.24, p<.04); those who developed Non-Alcohol SUD started treatment at a mean of 9.10 ± 1.74 years versus 8.52 ± 1.55 years for those who did not (t(174)=2.31, p=.02).
- Late-treated probands (treatment began at ages 8–12) had higher lifetime SUD rates than early-treated probands (ages 6–7) (44% vs. 27%, Wald χ²=5.38, p<.02) and than non-ADHD comparisons (44% vs. 29%, Wald χ²=6.36, p<.02); early-treated probands did not differ from comparisons (27% vs. 29%, Wald χ²=0.12, p>.10).
- Antisocial personality disorder explained the treatment-initiation–SUD relationship: age at initiation remained associated with APD when SUD was covaried (Wald χ²=7.67, p<.01), but the initiation–SUD association disappeared when APD was controlled (Wald χ²=0.09, p=.76).
- Age at initiation was unrelated to mood disorders (Wald χ²=1.35, p>.10) or anxiety disorders (Wald χ²=0.40, p>.10).
Methods
- Prospective longitudinal study of 176 methylphenidate-treated white boys (ages 6–12) with ADHD but without conduct disorder, plus 178 non-ADHD male comparisons matched for age, social class, and geographic residence; follow-ups occurred at mean ages 18.4 ± 1.3 years (94% retention) and 25.3 ± 1.3 years (85% retention).
- Cox proportional hazards models included nine childhood predictors: age at methylphenidate initiation, total cumulative dose, treatment duration, Full Scale IQ, severity of hyperactivity, socioeconomic status, and lifetime mental disorder in mother, father, or either parent; outcomes were Any SUD, Alcohol SUD, Non-Alcohol SUD, and Stimulant SUD, with post-hoc analyses for antisocial personality disorder, mood, and anxiety disorders.
- Diagnoses were made by clinicians blind to childhood status using adolescent and adult interviews, including a modification of the Diagnostic Interview Schedule, the Teenager Or Young Adult Schedule, the Schedule for the Assessment of Conduct, Hyperactivity, Anxiety, Mood, and Psychoactive Substances, and parent interviews.
Limitations
- The paper states it is an experiment of nature using a referred clinical sample; age at referral was not experimentally controlled, so unidentified non-random factors related to treatment initiation may have contributed, and replication is essential.
- The paper states the sample was ethnically homogeneous, excluded females, and had a minimum age of 6, restricting generalizability to clinic-referred 6–12 year old white males; it also cannot differentiate effects of stimulant medication from effects of age at referral or duration of untreated ADHD.
- Evident from the text: the observational design cannot establish causality, and despite controlling for several childhood and parent variables, residual confounding by unmeasured family or parenting factors remains possible.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 14 Not checked · 67 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Results showed that age at stimulant initiation significantly predicted SUD outcome when controlling for offset of ADHD (Wald χ2 = 3.78, p = .05), but age at offset of ADHD did not predict development of SUD when controlling for age at stimulant initiation (Wald χ2 = 2.51, p > .10).”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Two predictor variables had p-values less than .20: age at initiation of treatment (Wald χ2 = 4.92, p < .03) and socioeconomic status (Wald χ2 = 2.86, p < .09).”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“None of the predictors accounted for this association.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was a significant positive relationship between age at treatment initiation and Non-Alcohol SUD.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Among the 176 treated participants, 80 (45%) fulfilled criteria for SUD at some time in their lives.”
plainn = 176- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
48 more claims
Create a free account to see all 81 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 23
- The quote only partly states this claim. 1
- It may state two separate claims as one. 9
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, there were no differences in lifetime SUD between ADHD youth with early onset of MPH therapy and non-ADHD youth.30”
From Is Age of Onset and Duration of Stimulant Therapy for ADHD Associated with Cocaine, Methamphetamine, and Prescription Stimulant Misuse? (2024) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These findings support data derived from smaller clinical studies that early initiation of stimulant treatment for ADHD is not associated with an increased risk of illicit stimulant misuse relative to later onset of treatment, and that the resulting risk is actually similar to that in the general population.30”
From Is Age of Onset and Duration of Stimulant Therapy for ADHD Associated with Cocaine, Methamphetamine, and Prescription Stimulant Misuse? (2024) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is growing evidence that initiation of ADHD stimulant therapy in secondary school or later may represent a sensitive developmental period that deserves greater clinical and research attention.26,29,30”
From Is Age of Onset and Duration of Stimulant Therapy for ADHD Associated with Cocaine, Methamphetamine, and Prescription Stimulant Misuse? (2024) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While childhood treatment of ADHD with stimulants does not increase substance abuse at a later age (40), it is also true that longer-term treatment of the disorder is more usual today.”
From Pediatric psychopharmacology: Too much or too little? (2013) · cites this paper as [40]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although clinical studies have examined stimulant therapy for ADHD and subsequent risk for SUD, [30][31][32][33][34][35][36] these studies suffer from limitations such as small homogeneous samples, non-random sampling, and lack of attention toward both non-stimulant and stimulant therapy for ADHD.”
From Is Age of Onset and Duration of Stimulant Therapy for ADHD Associated with Cocaine, Methamphetamine, and Prescription Stimulant Misuse? (2024) · cites this paper as [30]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Consistentt(174) = 2.31reported p = .02 · recomputed p = .022
“t (174) = 2.31, p = .02”
- Consistentr(176) = 0.05reported p = .49 · recomputed p = .507
“r(176) = .05, p = .49”
- Consistentr(176) = -0.05reported p = .54 · recomputed p = .507
“r(176) = −.05, p = .54”
- Consistentr(176) = -0.06reported p = .45 · recomputed p = .426
“r(176) = −.06, p = .45”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
Robins, L. N. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780290015001 · Cited by 5,219
Wechsler Intelligence Scale for Children
(2018) · The SAGE Encyclopedia of Intellectual and Developmental Disorders · doi:10.4135/9781483392271.n537 · Cited by 4,109
Social class and mental illness: Community study.
Hollingshead, A. B., & Redlich, F. C. (1958) · John Wiley & Sons, Inc. eBooks · doi:10.1037/10645-000 · Cited by 3,738
Social Class and Mental Illness
Hunt, R. G., Hollingshead, A. B., & Redlich, F. C. (1959) · The American Journal of Psychology · doi:10.2307/1420236 · Cited by 3,282
Applied Survival Analysis: Regression Modeling of Time-to-Event Data
Hosmer, D. W., Lemeshow, S. A., & May, S. J. (2008) · Cited by 3,030
ROBINSON, T., & BECKER, J. (1986) · Brain Research · doi:10.1016/s0006-8993(86)80193-7 · Cited by 2,106
Social Class and Mental Illness: A Community Study
(2007) · American Journal of Public Health · doi:10.2105/ajph.97.10.1756 · Cited by 1,840
Research works printed but not linked: 8
- Milberger S, 1997, Am J Addict, 6, 318
- Schenk S, 1998, NIDA Res Monogr, 169, 56
- Loney J, 2002, Attention Deficit Hyperactivity Disorder: State of the Science Best Practices, 1
- Gittelman R, 1980, Hyperactive Children, 221
- Wechsler D, 1949, Wechsler Intelligence Scale for Children
- Conners CK, 1973, Psychopharmacol Bull, 9, 24
- Mannuzza S, 1987, Hyperactivity, Anxiety, Mood, and Psychoactive Substances (CHAMPS).
- Hosmer DW, 1999, Lemeshow S: Applied Survival Analysis
Cited by
Lee, S. S., Humphreys, K. L., Flory, K., Liu, R., & Glass, K. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.01.006 · Cited by 875
“For example, Wilens, Faraone, Biederman, and Gunawardene (2003) reported that stimulant medication substantially reduced the risk for future substance problems, but two recent studies failed to replicate the protective effects of MPH (Biederman et al., 2008; Mannuzza et al., 2008).”
BackgroundAttention‐Deficit‐Hyperactivity Disorder: An Update
Dopheide, J. A., & Pliszka, S. R. (2009) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.6.656 · Cited by 645
van Emmerik-van Oortmerssen, K., van de Glind, G., van den Brink, W., Smit, F., Crunelle, C. L., Swets, M., & Schoevers, R. A. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.12.007 · Cited by 535
“The following exclusion criteria were used: - Studies reporting on juvenile offenders, as this is a distinct group of adolescents characterised by delinquent behaviour, which in turn is associated with ADHD (Sevecke et al., 2009; Mannuzza et al., 2008a,b; Foley et al., 1996).”
BackgroundMethodSharma, A., & Couture, J. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028013510699 · Cited by 516
“may decrease the risk of substance abuse,(61,62) with a more robust effect apparent when initiated at an earlier age.(63) Imaging studies indicate a similar neurobiology between individuals suffering from ADHD and substance abusers(64); thus, treating ADHD reduces substance abuse disorders concomitantly.”
BackgroundSensitive periods of substance abuse: Early risk for the transition to dependence
Jordan, C. J., & Andersen, S. L. (2017) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2016.10.004 · Cited by 455
“Studies both in humans (Biederman et al., 1999; Mannuzza et al., 2008; Wilens et al., 2003) and in rodents (Adriani et al., 2006b; Andersen et al., 2002a; Bolanos et al., 2003; Carlezon et al., 2003; Thanos et al., 2007) suggest that childhood or prepubertal exposure to stimulants reduces the…”
Influential
Metadata
- Authors
- Mannuzza, S., Klein, R. G., Truong, N. L., Moulton, J. L., Roizen, E. R., Howell, K. H., & Castellanos, F. X.
- Affiliations
- New York University (US)
- Venue
- American Journal of Psychiatry
- Published
- 2008-05
- Volume
- 165
- Issue
- 5
- Pages
- 604-609
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- PMC
- PMC2967384
- OpenAlex
- W2142868627
- Cited by
- 263
- References
- 44
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 6 · 2023: 13 · 2022: 12 · 2021: 9 · 2020: 5 · 2019: 15 · 2018: 7 · 2017: 11 · 2016: 14 · 2015: 24 · 2014: 22 · 2013: 19 · 2012: 29
- FWCI
- 15.92
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (MH-18579, R01MH018579)
- National Institute on Drug Abuse (DA-16979, R01DA016979)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- methylphenidate, attention deficit hyperactivity disorder, age at treatment initiation, stimulant medication, substance use disorders, alcoholism, antisocial personality disorder, long-term outcomes, childhood ADHD
- MeSH terms
- Adolescent, Adult, Age Factors, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Follow-Up Studies, Humans, Male, Methylphenidate, Parents, Prospective Studies, Surveys and Questionnaires, Observer Variation, Incidence, Prevalence, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. https://app.cochat.ai/papers/10.1176/appi.ajp.2008.07091465
- The paper
- Mannuzza, S., Klein, R. G., Truong, N. L., Moulton, J. L., Roizen, E. R., Howell, K. H., & Castellanos, F. X. (2008). Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2008.07091465
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.